Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial - Wikidata - awgldk - TriplyDB

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

http://www.wikidata.org/entity/Q36333526

about

Role of the tumor microenvironment in mature B-cell lymphoid malignancies Customized targeted therapy in Hodgkin lymphoma: hype or hope?Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells Pinellia pedatisecta agglutinin targets drug resistant K562/ADR leukemia cells through binding with sarcolemmal membrane associated protein and enhancing macrophage phagocytosis Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences Macrophages and dendritic cells as actors in the immune reaction of classical Hodgkin lymphoma Difference in distribution profiles between CD163+ tumor-associated macrophages and S100+ dendritic cells in thymic epithelial tumors.Clinical significance of sIL-2R levels in B-cell lymphomas.How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma.CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma.Tumor-Infiltrating Macrophages in Post-Transplant, Relapsed Classical Hodgkin Lymphoma Are Donor-Derived.Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma.CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma.Diverse in vivo effects of soluble and membrane-bound M-CSF on tumor-associated macrophages in lymphoma xenograft model.Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era CD163 and c-Met expression in the lymph node and the correlations between elevated levels of serum free light chain and the different clinicopathological parameters of advanced classical Hodgkin's lymphoma.Monocytes and macrophages in cancer: development and functions Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma.Advances in the treatment of Hodgkin lymphoma.New strategies in Hodgkin lymphoma: better risk profiling and novel treatments.Tumor-associated macrophages: functional diversity, clinical significance, and open questions.Controversies in the role of radiotherapy in the treatment of pediatric Hodgkin lymphoma.Clinical significance of macrophage heterogeneity in human malignant tumors.Current status of prognostication in classical Hodgkin lymphoma.New targets for antibody therapy of pediatric B cell lymphomas.Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology.Role of tumor-associated macrophages in hematological malignancies.Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents.Drug Trafficking into Macrophages via the Endocytotic Receptor CD163.Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphoma.

P2860

Q26748775-8616D829-1166-4179-8FDC-570EB70ECE7D Q27002554-820FB154-F12D-483F-9D63-F4D40B9B022A Q28075701-7C4AC2DC-A932-43FC-9A42-BE759F7DE5F9 Q28083973-0D0A8505-32CB-4F6C-BB32-CB2EF36E541D Q28536615-F5C3A392-4E6D-44A1-8BFA-0AA4806E62A4 Q30412099-A1BE5CA8-8ACA-4129-8EB3-13B72BD4EC1A Q34354547-BA46ED0B-E6A5-4672-9E9C-290D1BE91BB3 Q34627838-8476FD9D-5F1E-484B-9DF4-32555F272FFA Q34998148-E67E3E19-9FDA-4796-916F-DAB76E8F3BC2 Q35043560-32BD7292-EF0B-4BB6-A890-F5FC43BF8C30 Q35103531-D74356A9-ACDD-4322-A478-E613B7D882CA Q35128470-9D4192AF-9E3A-4DBC-A83A-756A9EA62F8B Q35661295-9FC21CCF-9B62-4EED-BA8A-F0F2546D06F9 Q36148619-1C0890D3-941B-4152-918E-B893EB296A7D Q36164491-B316361F-178D-4E6A-AD97-8845607F8BC3 Q36582785-DB6DDBD9-5E53-41C2-985E-E2162BA55287 Q36673451-7FE4DE86-1F76-4E53-8E96-0BC78902DB94 Q36691438-31D8B8A5-5DF1-40A6-910D-F71611D2C53C Q36706850-7E1F497F-3437-4F4C-88BF-969CD01E3676 Q36738826-B4827489-8757-4BCF-AC28-34EDC5FB745D Q36814594-E21A1D07-E06D-4617-9E54-57A1E2EE8374 Q36939926-8CBAC9FC-57D3-4458-B363-52214FDD9EB0 Q36973329-E1B09077-A179-496F-BD09-7EAA9A90B549 Q37028772-41C0FEDF-BD0C-44CB-AE75-778A1C23874B Q37108162-193954AC-172F-4A31-9CA8-430FEA4762A5 Q37297662-D60F178F-D553-427A-818A-2AFE403185F7 Q37384289-6102D576-1FC7-4F2C-88EC-DD14317965AE Q37529430-CD8F8B40-4012-4323-B173-FFA8669F2F8C Q38051197-45DC302A-EA1C-4F57-A4D7-7F0ED133CCF8 Q38085250-6F89CDAB-9722-49CF-9BCC-23EF18392D52 Q38105286-66298263-25F4-480E-8E3C-551BE107307B Q38131410-EB5E994E-E940-4882-AA0F-AD618140473D Q38156195-38240D91-16CA-4FA7-ACDE-66E2A33BE0E7 Q38185063-63FBE4ED-7A28-43BA-BF6C-148BDB2A3DD4 Q38242984-FEA4D877-C399-477C-8A70-3DF9CE3340C6 Q38323254-CB9C628B-2095-4D5D-BB2C-E438FE44EE1C Q38364405-381B05D2-AA0B-476D-8667-D09775D74D7A Q38396485-57881864-6E96-422A-BAE6-DD404FAB5B1A Q38537751-65D995FC-D823-4C64-83AB-2767BEA4B5FF Q38557033-DEEAE68E-4676-46E5-A899-BCBC66CA7EFA

P2860

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

http://www.wikidata.org/entity/Q36333526

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Tumor-associated macrophages p ...... rom the E2496 Intergroup trial

@ast

Tumor-associated macrophages p ...... rom the E2496 Intergroup trial

@en

type

label

Tumor-associated macrophages p ...... rom the E2496 Intergroup trial

@ast

Tumor-associated macrophages p ...... rom the E2496 Intergroup trial

@en

prefLabel

Tumor-associated macrophages p ...... rom the E2496 Intergroup trial

@ast

Tumor-associated macrophages p ...... rom the E2496 Intergroup trial

@en

P1433

Q36333526-48761835-9B91-4478-A976-A4C609FD784B

P1476

Q36333526-D71AD06B-7652-4A00-BEE4-262DE83BCB02

P2093

Q36333526-0C6B4695-CECB-421E-905F-88ABA2C4249B

Q36333526-33D6F947-087C-46C5-B538-1A06EA2893C7

Q36333526-41A89EEC-9CB9-483F-B81A-9F1A501F2B7F

Q36333526-628F51CE-1929-4319-8DE6-9159A289C48A

Q36333526-7053758F-D847-407C-B4FA-7F6D6C0A1DA8

Q36333526-9AE2303B-96D9-47EE-BCC1-162E6F803CE0

Q36333526-A25AFB3A-FD38-4256-8573-955A19EBF08F

Q36333526-C375D853-20D0-4F41-91C6-C23AB5DE0718

Q36333526-C8FAC618-0536-4FA8-BBC3-02905785005C

Q36333526-D74042F8-C3FC-4521-B0DD-24CFBBAE963C

P2860

Q36333526-0CF335CB-C489-422A-AD79-9B4CF4F157BF

Q36333526-104FE865-3081-43C1-A586-41EB3A28D446

Q36333526-1A78DC2F-A0F1-4098-90B7-39BB4E88072E

Q36333526-1BCB5FA4-8F90-4CA8-8490-A7981C3E008A

Q36333526-247CC685-0983-400D-9B28-6A3A500316C2

Q36333526-2BA8F97A-0B2D-4F64-93B6-AC3C46F37FDC

Q36333526-5CC60502-A450-4C39-AEE9-FDF6C1468862

Q36333526-5E605EB7-5E52-4742-928E-2B4C2DC3B3FD

Q36333526-66F01459-9486-452E-B4D2-7AA9A75043A1

Q36333526-71B430B8-FDBA-4613-9FEC-73E77BCDEF44

P304

Q36333526-38B3AE41-7A6A-48F6-B94D-0B08597CC0F1

P31

Q36333526-D4DB8C47-F253-4B30-8973-7682B8231F1D

P356

Q36333526-263CE215-3FE7-4C21-B1C0-C38F71017EC5

P407

Q36333526-7321865C-D120-47BC-9BCD-B5136A58F3A8

P433

Q36333526-84C808FD-6943-4002-8F3E-CD4D4778D8C3

P478

Q36333526-6C482B92-5224-430E-94BB-1771279A4CDC

P50

Q36333526-03112FEB-8B33-451C-82F0-12565FF19AA9

Q36333526-43A23F08-AF61-47EA-8FAD-83F4755D8E7A

Q36333526-C6D146EA-9B15-427D-85C7-BE4FFD6C52BA

Q36333526-DD44264E-18AA-4E8A-97DB-6FC4107693C7

P577

Q36333526-1C27D116-2C1F-40BA-931A-59DCB09D9830

P5875

Q36333526-7FA2C3FA-AEC5-4BF7-9EA4-DBDFC89899DF

P698

Q36333526-22240A32-F2B3-486C-9AE5-B85A7CCF7038

P921

Q36333526-12303022-D05F-4020-8C1E-736ADC4DAB0A

P932

Q36333526-FDC500E2-D924-4684-AD67-0E13D025D4A8

P356

BLOOD-2012-04-421057

P1433

P1476

Tumor-associated macrophages p ...... rom the E2496 Intergroup trial

@en

P2093

Brad S Kahl

http://www.w3.org/2001/XMLSchema#string

Christian Steidl

http://www.w3.org/2001/XMLSchema#string

David W Scott

http://www.w3.org/2001/XMLSchema#string

Fangxin Hong

http://www.w3.org/2001/XMLSchema#string

King L Tan

http://www.w3.org/2001/XMLSchema#string

Lisa M Rimsza

http://www.w3.org/2001/XMLSchema#string

Ranjana H Advani

http://www.w3.org/2001/XMLSchema#string

Rena Buckstein

http://www.w3.org/2001/XMLSchema#string

Richard I Fisher

http://www.w3.org/2001/XMLSchema#string

Sandra J Horning

http://www.w3.org/2001/XMLSchema#string

P2860

Exploring the full spectrum of macrophage activation

Protective and pathogenic functions of macrophage subsets

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

CD163: a specific marker of macrophages in paraffin-embedded tissue samples.

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.

Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment.

Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry.

CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.

Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.

P304

3280-3287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2012-04-421057

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

Joseph M Connors

Nancy L Bartlett

Randy D Gascoyne

P577

2012-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230796989

http://www.w3.org/2001/XMLSchema#string

P698

22948049

http://www.w3.org/2001/XMLSchema#string

P921

P932

3476539

http://www.w3.org/2001/XMLSchema#string